Maxim Group reiterated a Buy rating on Gilead Sciences (NASDAQ: GILD), and raised the price target to $137.00 (from $129.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Pre-Open Stock Movers 10/28: (CMI) (HOT) (CAB) (AIG) (AAPL) Higher; (MCUR) (AKAM) (ICPT) Lower (more...)October 28, 2015 9:31 AM Gilead Sciences (GILD) PT Raised at Cowen as HCV Sales Drive BeatOctober 28, 2015 8:53 AM Gilead Sciences (GILD) Bullish Stance Reiterated at Oppenheimer Amid 'Beat and Raise' QtrOctober 28, 2015 6:25 AM After-Hours Movers 10/27: (VCRA) (NOC) (CRUS) Higher; (AKAM) (TWTR) (RAD) Lower (more...)October 27, 2015 6:26 PM Gilead (GILD) Slips Despite Strong Q3 ResultsOctober 27, 2015 4:13 PM Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; 1.6% YieldOctober 27, 2015 4:03 PM Gilead Sciences (GILD) Tops Q3 EPS by 33c, Updates FY15 GuidanceOctober 27, 2015 4:02 PM Gilead Sciences Announces Third Quarter 2015 Financial ResultsOctober 27, 2015 4:00 PM Gilead Sciences Announces Fourth Quarter 2015 DividendOctober 27, 2015 4:00 PM Valeant Pharma (VRX) Short Interest Rose 49% Before Citron's 'Smoking Gun'October 26, 2015 5:20 PM Trading Radar for 10/26: Apple (AAPL), Twitter (TWTR), Alibaba (BABA), Comcast (CMCSA), Pfizer (PFE) ReportOctober 26, 2015 2:16 PM